Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Bedside Spirometry to see if tidal volume matches ideal body weight in non-intubated ARDS

Official title: Correlation Between Tidal Volume in Spontaneous Ventilation and Tidal Volume in Non-invasive Ventilation in Acute Hypoxemic Non-hypercapnic Respiratory Failure

Run by Centre Hospitalier Departemental Vendee · NCT07750717 · Data updated 2026-11-12

This pilot study tests whether tidal volume measured at bedside with high-flow oxygen and after NIV settings can help classify ARDS patients who are not intubated.

More Respiratory Insufficiency trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorCentre Hospitalier Departemental Vendee
Academic / other
Locations2 sites (La Roche-sur-Yon and 1 other locations)
StatusRecruiting
StartedOctober 16, 2026
Main results expectedOctober 16, 2026
Study endsApril 16, 2029
Registry record updatedOctober 19, 2026
Trial IDNCT07750717 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (>18) hospitalized in ICU within 24 hours, with severe hypoxemic ARDS (PaO2/FiO2 150–299) on high-flow oxygen, able to cooperate with spirometry and consent.

Probably not a fit

Patients requiring immediate intubation or with contraindications to NIV, instability, or refusal to participate may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study uses a handheld spirometer to compare tidal volumes during high-flow oxygen therapy and during non-invasive ventilation with optimized settings in adults with severe hypoxemic ARDS. The aim is to see if a relationship between tidal volumes across these two respiratory supports helps define ARDS phenotypes without intubation. It is designed as an early-phase, exploratory assessment in ICU patients within 24 hours of admission. Interventions include a handheld spirometer and non-invasive ventilation; enrollment requires informed consent and eligibility per predefined respiratory and stability criteria. The study is conducted at CH Vendée and Nantes in France under a Centre Hospitalier sponsor, with no listed collaborators.

Why it matters

Potential benefit: If successful, the approach could help clinicians tailor non-invasive strategies for ARDS by identifying patients who may benefit from or be at risk with NIV.

How similar studies have gone: Previous work suggests tidal volume and respiratory physiology parameters can inform ARDS management, but this exact bedside phenotyping with NIV versus high-flow oxygen is exploratory and not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient over 18 years of age;
* Patient hospitalized in intensive care for less than 24 hours;
* Patient with severe hypoxemic acute respiratory failure characterized by a PaO2/FiO2 ratio \< 300 mmHg and \> 150 mmHg under high-flow oxygen therapy at 60 L/min;
* Patient able to cooperate with the spirometry test;
* Patient able to follow the protocol and having given their informed written consent to participate in the study;
* Patient affiliated with the social security system or entitled to benefits;

Exclusion Criteria:

* Patients with an indication for intubation;
* Patients with a contraindication for or who refuse NIV;
* Patients with hemodynamic instability requiring vasopressor support greater than 0.25 μg/kg/min of norepinephrine;
* Patients with a Glasgow score \< 15;
* Patients with hypercapnia (PaCO2 \> 45 mmHg);
* Patients with a PaO2/FiO2 ratio \< 150 mmHg;
* Patients with cardiogenic pulmonary edema;
* Patients who have already undergone a session of NIV in intensive care during this stay;
* Patients with chronic respiratory failure (home oxygen therapy or home non-invasive ventilation (excluding indications solely for sleep apnea syndrome));
* Patients who have recently had a pneumothorax;
* Patients who have recently undergone eye surgery (e.g., cataract surgery) or throat surgery;
* Patients with significant arterial disease: recent heart attack, pulmonary embolism, poorly controlled hypertension despite treatment, etc.
* Patients already included in the study;
* Pregnant women, women in labor, or women who are breastfeeding;
* Patients under guardianship, conservatorship, or deprived of their liberty;
* Patients under an activated future protection mandate;
* Patients under family authorization;
* Patients under judicial protection;

Where it's running

  • CHD Vendée
    La Roche-sur-Yon, France
    Recruiting
  • Centre Hospitalier Universitaire de Nantes - Hôpital Hôtel Dieu
    Nantes, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.